How Much Does Chin Filler Cost?

We could not confirm a per-syringe price for any specific filler product on manufacturer or ASPS pages when we checked on October 20, 2026.

Allergan, which makes Juvéderm Voluma XC, does not publish a price on its Juvéderm FAQ — it says pricing varies by the Juvéderm product used, the amount of product used and the provider.

The closest national anchor is ASPS's dermal-filler cost page, which lists an average cost of $715 for hyaluronic acid fillers per its latest statistics.

The three chin-approved fillers are all hyaluronic acid gels, so a treatment with one of them falls into that category — but $715 is a national average physician fee across filler procedures, not a med spa price, not a chin-specific price, and not a quote from any one practice.

ASPS also lists $901 for non-hyaluronic acid fillers such as Radiesse and Sculptra, and neither product is approved for the chin.

Which product is in the syringe is the other half of the price question, because it is also a regulatory one.

As of October 20, 2026, only three US fillers hold an FDA-approved chin indication: Juvéderm Voluma XC (approved for chin augmentation on June 12, 2020), Restylane Defyne (January 29, 2021) and Restylane Lyft with Lidocaine (November 4, 2025), all in patients over 21.

Defyne and Lyft are approved for mild to moderate chin retrusion.

Every other filler that gets injected into a chin is off-label for that use: the chin appears on no current US label for those products.

That list includes Restylane Refyne — Defyne's sister product, which holds no chin indication — along with the RHA collection, Radiesse and Juvéderm Volux.

What off-label means for a chin treatment, and how the approvals read in full, is covered in our chin filler guide.

• The product. Allergan names the specific product as a pricing variable, and with no published per-product price we could confirm, the product name on a quote is what makes two prices comparable.
• The amount used. Allergan's second variable — the amount moves the total, which is why the syringe question below matters.
• The provider. Allergan's third variable: two practices can quote different totals for the same product and amount.

Amount is one of Allergan's three pricing variables, so the syringe count a treatment takes moves the total directly.

The published numbers for the chin are ceilings, not amounts to expect.

The Restylane Lyft label caps the chin at 4 mL per patient per treatment, including touch-up, and no more than 2 mL per injection site.

The Restylane Defyne label sets the same 4 mL maximum per patient per treatment, split as 2 mL in the chin plus 2 mL below the lower lip toward the pre-jowl sulcus.

Those maximums are safety limits written into the two Restylane labels — not recommended amounts, not typical amounts, and not a prediction for any chin.

We could not confirm a typical syringe count or an average treatment volume for chin filler in the sources we reviewed.

How much product a chin takes is an in-person assessment a licensed provider makes.

That is also why quotes need unpacking: ask how many syringes the price covers, how many milliliters that is, and what a touch-up session would cost if one is needed.

Two quotes with the same headline price can hide different amounts of product.

The surgical side has a national figure: ASPS's chin augmentation (mentoplasty) cost page lists an average cost of $3,641 per its latest statistics.

ASPS is explicit that the figure is only part of the total price — it does not include anesthesia, operating-room facilities or other related expenses, so the all-in cost of chin augmentation surgery runs above the surgeon's fee alone.

Filler has no matching figure in the sources we reviewed.

We could not confirm a per-syringe price for any specific product, and ASPS's $715 average for hyaluronic acid fillers is a category-wide physician-fee average rather than a chin price.

The two numbers are also different kinds of numbers: one is an average surgeon's fee for chin augmentation surgery, the other a national category average per procedure.

Repeat treatments are part of the filler cost picture.

Allergan's stated duration for Voluma XC in the chin is "up to 1 year with optimal treatment" — an upper bound under the maker's own wording, not a typical result or a promise.

When a result fades, the pricing Allergan describes applies again: the variables are still the product used, the amount used and the provider.

We found no source that prices filler against chin augmentation surgery directly, so the honest comparison is structure rather than a winner: quotes that scale with the amount of filler used on one side, a surgeon's fee plus the bills ASPS says it excludes on the other.

Whether filler or surgery fits a given chin is a question for a licensed provider.

National figures are background; the quote in front of you is the data.

Allergan's three pricing variables — the product, the amount and the provider — are all set practice by practice, and with no published per-syringe price we could confirm to check a quote against, the questions you take to a consultation are what make two quotes comparable.

• Which filler product, exactly, the quote assumes — and whether that product holds a chin indication.
• How many syringes the price covers, and how many milliliters that is.
• What a touch-up would cost if the result needs more product.
• What the practice charges if a result needs adjusting later.